• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

EMBL Ventures

edit

EMBL Ventures is an independent venture capital investor that engages in the financing and development of first-in-class products and technologies in the healthcare sector. Based on a strong scientific pedigree, the Fund strategy combines the core competencies of “Pharma” and “Biotech” to arrive at a scalable investment model that seeks at creating commercial value.

Recent Milestones

edit

• 
  EMBL Ventures invested in Opsona. (4/29/13)
  Posted 5/1/13 at 7:34pm via finsmes.com
• 
  EMBL Ventures invested in Allecra Therapeutics. (4/18/13)
  Posted 4/20/13 at 3:01am via yahoo.com
• 
  EMBL Ventures invested in ELARA Pharmaceuticals. (11/26/09)
  Posted 11/30/09 at 1:31pm via elarapharma.com
• 
  EMBL Ventures invested in immatics biotechnologies. (4/15/05)
  Posted 7/5/10 at 3:14am

Investments

Videos

Sources

1. EMBL Ventures Gathers EUR40M Toward Second Biomed Fund (fis.dowjones.com) [edit]
2. Opsona Therapeutics Raises €33M in Series C Financing (finsmes.com) [edit]
3. Edmond de Rothschild Investment Partners co-leads the €15 Million Series A financing of Allecra Therapeutics with its new fund BioDiscovery 4 (finance.yahoo.com) [edit]
4. ELARA Pharmaceuticals (elarapharma.com) [edit]
5. EDGAR [edit]